Veliparib-Chemo Combo New Option for BRCA-Mutated Breast Cancer? Veliparib-Chemo Combo New Option for BRCA-Mutated Breast Cancer?

AbbVie reports that upfront veliparib maintains carboplatin-paclitaxel response, with manageable side effects.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news